Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions - Related Studies

Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions

This study has been completed.

Study NCT00601575. Last updated on January 31, 2008. Information provided by Roxane Laboratories

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bipolar Disorder

2	More general conditions related to this trial
		Affective Disorders, Psychotic
		Mental Disorders
		Mood Disorders

3	Interventions listed in this trial
		Lithium

4	Additional drug interventions recognized in this trial
		Lithium Carbonate

5	More general drug interventions related to this trial
		Antidepressive Agents
		Antimanic Agents
		Antipsychotic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		Roxane Laboratories